Online Media Kit
Welcome to IPM's Online Media Kit, home to quick links that connect journalists and others to our press statements, key multimedia resources for background information on microbicides and IPM's work, and media highlights. Also learn how to contact experts in the field.
Quick Links
- Press Releases & Statements
- Multimedia
- IPM: Pioneering HIV prevention options for women (Fact sheet)
- Microbicide Overview (Fact sheet)
- A Long-Acting Vaginal Ring (Fact sheet)
Featured Media Highlights
FEATURED STORY
March 06, 2018 | POZ
Vaginal Ring Appears to Cut Women's HIV Rate in Half in New Study
The open-label follow-up to a previous placebo-controlled study of an HIV-preventing ring is seeing high use among women. More »
FEATURED STORY
December 19, 2017 | BBC World Hacks
The Ring That Could Help Save Women's Lives (AUDIO)
A new form of protection being tested in Malawi could be a real game-changer. World Hacks meets the women pioneering this approach and taking control of their own protection. More »
FEATURED STORY
May 04, 2017 | Economist (UK)
How to protect women against both HIV and pregnancy
A newly-developed vaginal ring releases small doses of drugs over a three-month period More »
FEATURED STORY
February 26, 2016 | The New York Times editorial
Helping Women in Africa Avoid H.I.V.
Now, women in the developing world have new hope. The results of two major studies in Africa that were released Monday show that a new device could help protect women against H.I.V. More »
Media Highlights
March 06, 2018 | POZ
Vaginal Ring Appears to Cut Women's HIV Rate in Half in New Study
The open-label follow-up to a previous placebo-controlled study of an HIV-preventing ring is seeing high use among women. More »
December 21, 2017 | POZ
Human Trial of 3-Month HIV-Preventing Vaginal Ring Begins
Researchers have launched an early human trial of an HIV-preventing vaginal ring that requires replacement every three months. More »
December 13, 2017 | Healio / Infectious Disease News
3-month vaginal ring for HIV prevention enters clinical trial
IPM announced the launch of a phase 1 clinical trial that will evaluate a vaginal ring that slowly releases the non-nucleoside reverse transcriptase inhibitor dapivirine over 3 months to prevent HIV... More »
December 08, 2017 | POZ
Do HIV-Preventing Microbicides Have a Future in the Age of PrEP?
Global research into new HIV prevention products stands at a crucial crossroads, and the future of topical microbicides may hang in the balance. More »
December 07, 2017 | Fyens Stiftstidene (Denmark)
The fight against HIV. Women should be able to decide over their own body. (translated)
An op-ed by Ulla Tørnæs, Dansh Minister for Development Cooperation, and Claus Kvist Hansen, Development Rapporteur, on why the Danish government is supporting IPM to advance microbicides for women. More »